Madrigal Pharmaceuticals, Inc.
MDGL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001157601
In the last 90 days, Madrigal Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 3 sales; 414 institutions reported holding it in 13F filings for Q2 2026, worth $12.7B in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Madrigal Pharmaceuticals, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 151 | 133 | −18 |
| Shares | 11.2M | 11.0M | −250.2K (−2.2%) |
| Value | $1.09B | $876.5M | −$217.4M (−19.9%) |
New holders (8)
Institutions that held Madrigal Pharmaceuticals, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Oracle Investment Management Inc | 38,500 | $3.07M | 0.39% |
| Point72 Asset Management, L.P. | 30,100 | $2.40M | 0.01% |
| Skandinaviska Enskilda Banken AB (publ) | 17,800 | $1.42M | 0.01% |
| Susquehanna Fundamental Investments, LLC | 8,641 | $689.0K | 0.01% |
| Ergoteles LLC | 6,090 | $486.0K | 0.02% |
| Campbell & CO Investment Adviser LLC | 5,000 | $399.0K | 0.13% |
| Connor, Clark & Lunn Investment Management Ltd. | 2,574 | $205.0K | 0.00% |
| Dark Forest Capital Management LP | 17 | $1.00K | 0.00% |
Sold out (26)
Institutions that held Madrigal Pharmaceuticals, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.